Press Releases
Filters
July 31, 2023
Viatris Announces Launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
June 13, 2023
Viatris Statement Regarding Submission of Application Seeking Approval for a Generic to Tyrvaya®
May 30, 2023
Viatris Named to USA Today's Inaugural List of America's Climate Leaders 2023
May 22, 2023
Robert J. Coury to Transition from Executive Chairman of Viatris to Chairman Emeritus and Senior Strategic Advisor to the Board and Management at the End of the Year
May 22, 2023
Viatris Announces Appointment of Leo Groothuis to Company's Board of Directors
May 17, 2023
Viatris to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
May 16, 2023
Viatris Publishes Sustainability Report Showcasing 2022 Progress on Building Sustainable Access to Medicine
May 8, 2023
Viatris Reports Strong Financial and Operational Results for First Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]
April 24, 2023
Viatris and Mapi Pharma to Highlight Latest Results of Multiple Sclerosis Research at American Academy of Neurology 75th Annual Meeting
Displaying 111 - 120 of 190